A new approach to second-line therapy for urothelial cancer?

Guru Sonpavde, Matthew D. Galsky, Joaquim Bellmunt

Research output: Contribution to journal › Letter › peer-review

8 Scopus citations

Original language	English
Pages (from-to)	682-684
Number of pages	3
Journal	The Lancet Oncology
Volume	14
Issue number	8
DOIs	https://doi.org/10.1016/S1470-2045(13)70175-X
State	Published - Jul 2013
Externally published	Yes

Access to Document

10.1016/S1470-2045(13)70175-X

Cite this

@article{72abde251fa14d3abf0da12af09f427d,

title = "A new approach to second-line therapy for urothelial cancer?",

author = "Guru Sonpavde and Galsky, {Matthew D.} and Joaquim Bellmunt",

year = "2013",

month = jul,

doi = "10.1016/S1470-2045(13)70175-X",

language = "English",

volume = "14",

pages = "682--684",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "8",

}

TY - JOUR

T1 - A new approach to second-line therapy for urothelial cancer?

AU - Sonpavde, Guru

AU - Galsky, Matthew D.

AU - Bellmunt, Joaquim

PY - 2013/7

Y1 - 2013/7

UR - http://www.scopus.com/inward/record.url?scp=84879783405&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(13)70175-X

DO - 10.1016/S1470-2045(13)70175-X

M3 - Letter

C2 - 23706984

AN - SCOPUS:84879783405

SN - 1470-2045

VL - 14

SP - 682

EP - 684

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 8

ER -